| Summary of Net Revenue, Cost of Sales, Operating Profit, Depreciation and Amortization, Interest Expense, Income Tax Benefit (Expense), Other Comprehensive Income, and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales, depreciation and amortization, operating profit, interest expense, and income tax (expense) benefit for the three months ended February 29, 2020 and February 28, 2019:
|
|
|
|
|
|
|
|
|
| |
|
For the three
months
ended February 29,
2020 |
|
|
For the three months
ended February 28,
2019 |
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
7,406,288 |
|
|
$ |
7,335,027 |
|
|
|
|
60,407 |
|
|
|
25,720 |
|
Public cord blood banking |
|
|
154,079 |
|
|
|
134,365 |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
7,620,774 |
|
|
$ |
7,495,112 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
2,055,075 |
|
|
$ |
2,038,616 |
|
|
|
|
41,117 |
|
|
|
160,006 |
|
Public cord blood banking |
|
|
406,952 |
|
|
|
267,605 |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
2,503,144 |
|
|
$ |
2,466,227 |
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
37,327 |
|
|
$ |
47,917 |
|
|
|
|
6,894 |
|
|
|
9,063 |
|
Public cord blood banking |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
Total depreciation and amortization |
|
$ |
44,221 |
|
|
$ |
56,980 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
1,489,548 |
|
|
$ |
1,130,251 |
|
|
|
|
12,396 |
|
|
|
(143,349 |
) |
Public cord blood banking |
|
|
(252,874 |
) |
|
|
(133,240 |
) |
|
|
|
|
|
|
|
|
|
|
|
$ |
1,249,070 |
|
|
$ |
853,662 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
365,299 |
|
|
$ |
406,925 |
|
|
|
|
— |
|
|
|
— |
|
Public cord blood banking |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
365,299 |
|
|
$ |
406,925 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
252,380 |
|
|
$ |
104,667 |
|
|
|
|
— |
|
|
|
— |
|
Public cord blood banking |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
252,380 |
|
|
$ |
104,667 |
|
|
|
|
|
|
|
|
|
|
The following table shows the assets by segment as of February 29, 2020 and November 30, 2019:
|
|
|
|
|
|
|
|
|
| |
|
As of February 29,
2020 |
|
|
As of November 30,
2019
|
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
31,001,108 |
|
|
$ |
28,975,002 |
|
|
|
|
270,095 |
|
|
|
289,804 |
|
Public cord blood banking |
|
|
13,459,243 |
|
|
|
13,621,354 |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
44,730,446 |
|
|
$ |
42,886,160 |
|
|
|
|
|
|
|
|
|
|
|